Skip to search formSkip to main contentSkip to account menu

Sinemet CR

Known as: Sinemet CR4, cr sinemet 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Carbidopa / Levodopa
Sinemet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A compact Q-switched and mode-locked diode-pumped Nd:GdVO4 laser with Cr4+:YAG Cr4
We demonstrated a diode-pumped passively Q-switched mode-locked (QML) Nd:GdVO 4 laser using a Cr 4+ :YAG saturable absorber with… 
2005
2005
Infrared (1.2-1.6 microm) luminescence in Cr4+:Yb3Al5O12 single crystal with 940 nm diode pumping.
1999
1999
Evaluation of equivalent efficacy of sinemet and sinemet CR in patients with Parkinson's disease applying levodopa dosage conversion formula.
We report ease of conversion, effect on equivalent efficacy and frequency of dosing when immediate-release carbidopa/levodopa… 
Review
1998
Review
1998
Pharmacoeconomic Analysis of Using Sinemet CR over Standard Sinemet in Parkinsonian Patients with Motor Fluctuations
OBJECTIVE: To compare the costs of pharmacotherapy in patients with Parkinson's disease before and after converting from standard… 
1995
1995
Resonance Raman scattering in Cr4+-doped forsterite.
1989
1989
An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group.
The safety and efficacy of Sinemet CR were studied in an open-label, 52-week trial. The study was completed by 156 mildly to… 
1989
1989
Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease.
The combination of carbidopa and levodopa (Sinemet) is a highly effective treatment for the symptoms of Parkinson's disease… 
1989
1989
Long-term clinical efficacy of Sinemet CR in patients with Parkinson's disease.
Sinemet CR, a controlled-release form of carbidopa/levodopa, was administered for 36 or 39 months to 8 patients with Parkinson's… 
1989
1989
Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease.
The efficacy of Sinemet CR4 (50/200) was compared to standard Sinemet (25/100) in an open label crossover study in 22 patients… 
1989
1989
Treatment of early Parkinson's disease with controlled-release levodopa preparations.
Therapeutic responses to Sinemet CR were studied in 37 patients with early Parkinson's disease previously treated with standard… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)